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Introduction
Ectopic pregnancy rates are steadily increasing, with an
estimated incidence of 16 per 1,000 reported pregnan-
cies [1]. Extremely rare locations of ectopic pregnancies,
such as within a scar, have been reported.
A pregnancy occurring within a cesarean section
scar is associated with the risk of rupture and hemor-
rhage. However, early diagnosis and conservative treat-
ment can preserve fertility. We report two cases of
cesarean section scar pregnancy that were successfully
treated with a combination of direct local injection and
systemic multidoses of methotrexate.
Case Reports
Case 1
A 39-year-old woman, gravida 4, para 2, with a history
of two previous cesarean sections (mal-presentation
was the reason for the first cesarean section), visited
our clinic on July 11, 2002 due to vaginal spotting
and delayed menstruation. Transvaginal sonography
revealed an empty uterine cavity and a gestational sac
corresponding to five weeks’ gestation located in the
anterior lower segment of the uterus (Figure 1). The
patient was admitted on July 15, 2002, with a serum
β-human chorionic gonadotropin (β-hCG) level of
27,153 mIU/mL. Under general anesthesia and trans-
abdominal sonographic guidance, methotrexate (MTX)
50 mg was injected through the cervix into the gestational
sac. Multiple doses of 50 mg MTX were injected intra-
muscularly on days 3, 5, and 7, with 15 mg oral calcium
folinate administered on the days after systemic MTX.
During the treatment period, the patient experienced
lower abdominal discomfort and an episode of vaginal
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bleeding. Her serum β-hCG levels decreased dramatically
to 8,603 mIU/mL (less than 68.3% of the initial β-hCG
level) 1 week after beginning systemic MTX treatment
(Figure 2). The β-hCG level was undetectable 60 days
after treatment and, by 68 days after the initial diagnosis,
the gestational sac was not detected on sonography.
Case 2
A 38-year-old woman, gravida 5, para 1, with a pre-
vious history of cesarean section, visited our clinic on
June 10, 2002 because of vaginal bleeding and abdo-
minal fullness. Urine pregnancy test was positive; trans-
vaginal ultrasound revealed a gestational sac with an
irregular contour within the anterior uterine isthmus,
corresponding to 7 weeks’ gestation. It contained an
embryo 8.1 mm in crown–rump length, and having per-
sistent cardiac activity (Figure 3). The patient’s serum
β-hCG level was 65,585 mIU/mL. She was admitted the
Figure 1. Case 1: transvaginal sonograph shows cesarean
section scar implantation in the anterior lower segment of the
uterus.
Figure 2. Case 1: serum β-hCG levels. Day 1 was the date of
intragestational MTX injection. Systemic MTX treatment was
administered on days 3, 5, and 7.
Figure 3. Case 2: transvaginal sonograph indicates an embryo
with a crown–rump length of 8.1 mm implanted in the anterior
uterine isthmus.
Figure 4. Case 2: serum β-hCG levels. Day 1 was the date of
intragestational MTX injection. Three courses of multiple MTX
were administered: i) from days 3 to 7; ii) from days 14 to 20;
iii) from days 28 to 34.
next day under the diagnosis of cesarean section scar
pregnancy. To terminate the pregnancy, MTX 50 mg
was injected into the gestational sac under trans-
abdominal sonographic guidance, followed by multi-
ple doses of intramuscular MTX 50 mg on days 3, 5,
and 7, with 15 mg oral calcium folinate administered
on the days after systemic MTX. After her first course
of treatment, she was discharged without incident.
However, her serum β-hCG level remained high at
33,082 mIU/mL 7 days later. She received another
course of intramuscular MTX with calcium folinate
on days 1, 3, 5, and 7, beginning on July 24, 2002. She
experienced intermittent lower abdominal pain during
treatment. Her β-hCG level fell to 7,548 mIU/mL by the
end of this second round of therapy (Figure 4). A third
course of MTX treatment was prescribed on August 7,
2002. Weekly sonography screening showed fetal cardiac
arrest on the 16th day after starting treatment, followed
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by a gradual decrease in the size of the gestational
sac. Her β-hCG level decreased continuously and was
undetectable by the 63rd day after her initial diagnosis.
Discussion
Gestational implant in a previous cesarean section scar
is a rare form of ectopic pregnancy. The natural history
of the condition is unknown, and the most reasonable
hypothesis is entrance of conceptus into the myometrium
through a microscopic dehiscent tract of the cesarean
section scar. Like intramural implantation, such a tract
is believed to develop from the trauma of previous
uterine surgery, such as curettage, cesarean section,
myomectomy, metroplasty, hysteroscopy, and even the
manual removal of the placenta [2].
The risk of uterine rupture and uncontrolled bleed-
ing is high in cesarean section scar pregnancy, even in
the first trimester of pregnancy. Early diagnosis is critical
for offering multiple treatment options so that young
women who desire to preserve fertility can be manag-
ed conservatively. Diagnosis of ectopic pregnancy by
sonography was reported more than three decades ago
[3]. However, the use of ultrasound in detecting a
cesarean section scar pregnancy was not reported until
1990 [4]. Strict criteria in ultrasound imaging must be
used to differentiate cesarean section scar pregnancy
from spontaneous abortion in progress, cervico-isthmic
pregnancy, and tubal pregnancy. These criteria include
an empty uterine cavity, an empty cervical canal,
gestational sac located in the anterior part of the uterine
isthmus, and an absence of healthy myometrium between
the bladder and the sac [2]. Some authors suggest an
additional criterion of prominent peri-trophoblastic
flow in the diagnosis of cesarean section scar pregnancy
[5]. However, misdiagnoses still occur. Lai et al report-
ed difficulty in making a differential diagnosis between
an ectopic pregnancy implanted in the oviduct or in the
myometrium of a previous cesarean section scar, even
as early as the 7th week of gestation [6]. They suggest-
ed operative laparoscopy as a diagnostic tool. On the
other hand, Godin et al reported the use of magnetic
resonance imaging to confirm a diagnosis of cesarean
section scar pregnancy [7].
Because of the rarity of cesarean section scar
pregnancy, treatment guidelines are not available. A
variety of surgical and non-surgical options have been
proposed to terminate this particular type of ectopic
pregnancy. Surgical approaches include hysterectomy,
hysterotomy, and curettage. However, curettage in
cesarean section scar pregnancy is generally contraindi-
cated and may cause uterine perforation and intractable
bleeding. A review of the literature since the first case of
cesarean section scar pregnancy was reported in 1978
[8] revealed that hysterectomy was necessary in two
cases [3,9]. Other cases were successfully treated with
hysterotomy, either through laparotomy or laparosco-
pic surgery [10].
Medical treatment such as MTX injection has been
used in tubal pregnancy, but experience is limited in
cesarean section scar pregnancy. A single dose of syste-
mic MTX has been used to treat cesarean section scar
pregnancy [11,12]. However, others have claimed that
systemic multidoses of MTX are necessary for success-
ful management [13,14]. Alternatively, Godin et al re-
ported success using local injection of KCl and MTX
into a 9-week gestational sac [7], resulting in undetec-
table β-hCG levels by 82 days, and the disappearance of
the residual sac from ultrasound by 96 days. Roberts et
al used direct local injection of hyperosmolar glucose
followed by oral methotrexate three times daily for 5
days in a 7-week cesarean section scar pregnancy [15];
the β-hCG level became undetectable after 6 weeks,
with no evidence of a residual sac by ultrasound.
Our two cases responded well to direct injection of
MTX into the gestational sac, followed by systemic MTX
injections. Using serum β-hCG level as an indicator
for the need for further treatment, we found a 68.3%
decline of β-hCG level in case 1, but only a decline of
49.6% in case 2, 1 week after treatment. Levels of β-
hCG were high (33,082 mIU/mL) after treatment in
case 2, prompting two additional courses of systemic
MTX. In contrast, the patient in case 1 received only one
course of systemic MTX therapy. These results suggest
that the number of treatment courses required might
be related to gestational age at diagnosis and to the
presence of a fetal heartbeat. Unlike the experience with
single-dose MTX treatment in tubal pregnancies that
indicate a higher failure rate for patients with an initial
β-hCG level greater than 10,000 mIU/mL [16], treatment
guidelines that can predict outcome in cesarean section
scar pregnancies have not yet been established. How-
ever, after comparing the criteria for tubal pregnancy
with MTX treatment to our experience, direct MTX injec-
tion into the gestational sac of a cesarean section scar
pregnancy was successful in terminating the growth of
an embryo with cardiac activity and in patients with
higher β-hCG levels. Patients who choose medical treat-
ment that allows preservation of fertility may benefit
from avoiding the risk of surgery, but face an uncertain
treatment period and the possibility of treatment failure.
Our medical treatment of the cesarean section scar
pregnancies of our two patients was successful. However,
the evaluation of treatment results was based on the
outcome of only two cases. We do not know the overall
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success rate or the outcome of subsequent pregnancies
after treatment for cesarean section scar pregnancy.
Several authors have reported uneventful subsequent
pregnancy course after surgical repair [6,17], but the
integrity of the uterus after medical treatment is still
unclear. The risk of uterine rupture and the rate of
recurrent implantation in cesarean section scars after
medical treatment are unknown.
The large number of cesarean sections performed
around the world has caused concern, not only because
of the financial costs but also because of the immediate
maternal morbidity. Cesarean section is a modest risk
factor for ectopic pregnancy and an important risk
factor for placental problems [18]. In view of the
increasing rate of cesarean delivery, health care provi-
ders should be aware of the possibility of this ectopic
pregnancy type in subsequent pregnancies.
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